← Back to all trials
Not Yet Recruiting
NCT07676448
Performance of Amino Acid Positons Emission Tomography in Brain Metastases
Conditions: PET-CT
Sex: All
Ages: 18 Years – 90 Years
Healthy volunteers: No
Enrollment: 80
Sponsor: Central Hospital, Nancy, France
Summary
Differentiating radiation necrosis from tumor progression in patients with brain metastases has a major therapeutic and prognostic implications
Eligibility Criteria
Inclusion Criteria:
* Patients who received a PET amino acid for differentiating radiation necrosis from progression of irradiated brain metastases,
Exclusion Criteria:
* Patients who refused the using of their data
Source: ClinicalTrials.gov (NCT07676448). StuddyBuddy aggregates publicly available trial information.
